New HIV vaccine with a 97% antibody response rate in phase I human trials. This is the most effective trial HIV vaccine to date. It is based on the Moderna’s COVID vaccine. COVID tech acceleration could change Rx for cancer & HIV in future.
An effective, safe and accessible vaccine to the HIV/AIDS prevention and treatment will make a world of difference to the millions of people whose lives remain at risk from this disease more so in the Sab Saharan Africa. You see a break through in the Covid 19 vaccine also means a success for other diseases such as HIV/ AIDS and Malaria. We hope for the best…